Ketorolac Tromethamine
Brand name: Ketorolac Tromethamine
Rank #469 of 500 drugs by total cost
$15.6M
Total Cost
582,750
Total Claims
$15.6M
Total Cost
7,398
Prescribers
$27
Cost per Claim
355,547
Beneficiaries
677,157
30-Day Fills
$2,111
Avg Cost/Provider
79
Avg Claims/Provider
About Ketorolac Tromethamine
Ketorolac Tromethamine (sold as Ketorolac Tromethamine) was prescribed 582,750 times by 7,398 Medicare Part D providers in 2023, costing the program $15.6M. At $27 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 466 | Alpelisib (Piqray) | $15.7M | 747 |
| 467 | Doxazosin Mesylate (Doxazosin Mesylate) | $15.7M | 729,878 |
| 468 | Prucalopride Succinate (Motegrity) | $15.7M | 22,068 |
| 469 | Ketorolac Tromethamine (Ketorolac Tromethamine) | $15.6M | 582,750 |
| 470 | Tetrabenazine (Tetrabenazine) | $15.6M | 6,326 |
| 471 | Avatrombopag Maleate (Doptelet) | $15.4M | 1,156 |
| 472 | Primidone (Primidone) | $15.3M | 450,535 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology